|
| Total | MRB+ | MRB− | aOR (CI 95%) | p-value |
|
| n (%) | n (%) | n (%) |
|
|
| Surgery in 30 days |
|
|
|
| 0.75 |
| yes | 61 (24.7) | 37 (32.7) | 24 (17.9) | 1^ |
|
| No | 186 (75.3) | 76 (67.3) | 110 (82.1) | 1.4 (0.2 - 11.3) |
|
| Diabetis |
|
|
|
| 0.06 |
| yes | 79 (32.0) | 46 (40.7) | 33 (24.6) | 1^ |
|
| No | 168 (68.0) | 67 (59.29) | 101 (75.4) | 1.7 (0.9 - 2.9) |
|
| Antibiotic in 30 days |
|
|
|
| <0.001˚ |
| yes | 82 (33.2) | 56 (49.6) | 26 (19.4) | 1^ |
|
| No | 165 (66.8) | 57 (50.4) | 108 (80.6) | 3.2 (1.9 - 5.4) |
|
| Injectable treatment |
|
|
|
| 0.50 |
| yes | 20 (8.1) | 14 (12.4) | 5 (3.7) | 1^ |
|
| No | 227 (91.9) | 99 (87.6) | 129 (96.3) | 1.3 (0.7 - 2.5) |
|
| Indwelling surgery |
|
|
|
| 0.62 |
| yes | 20 (8.1) | 14 (12.4) | 6 (4.5) | 1^ |
|
| No | 227 (91.9) | 99 (87.6) | 128 (95.5) | 1.3 (0.6 - 2.5) |
|
| Spacies (staphylococcus aureus) |
|
|
|
| 0.02˚ |
| Yes | 80 (32.4) | 58 (51.3) | 22 (16.4) | 1^ |
|
| No | 167 (67.6) | 55 (48.7) | 112 (83.6) | 5.9 (1.3 - 26.3) |
|